螺旋β-乳蛋白酶体抑制剂的结构分析
Michael Groll1, Emily P Balskus, Eric N Jacobsen
1Center for Integrated Protein Science at the Department Chemie, Lehrstuhl für Biochemie, Technische Universität München, Lichtenbergstrasse 4, D-85747 Garching, Germany.
Journal of the American Chemical Society
|October 22, 2008
概括
研究人员开发了由 (+) - 乳素激素启发的新型螺旋β-乳蛋白酶体抑制剂. 一种化合物强烈抑制了26S蛋白酶体,而其表皮体则表现出弱活性,为药物设计提供了洞察力.
科学领域:
- 药用化学 医学化学
- 结构生物学 结构生物学
- 有机合成 有机合成
背景情况:
- 蛋白酶体是一个关键的细胞机器,参与蛋白质降解.
- 开发强效和选择性蛋白酶体抑制剂是药物发现的关键目标,特别是用于癌症治疗.
- 像 (+) - 乳糖素这样的天然产品可以作为设计新疗法剂的宝贵支架.
研究的目的:
- 为了合成和评估新的基于beta-lactone的螺旋化合物作为蛋白酶体抑制剂.
- 阐明由立体异构体对蛋白质体的差异性抑制的结构基础.
- 了解这些抑制剂的作用机制和结构-活性关系.
主要方法:
- 不对称的催化总合成 (+) - 乳糖素及其类似物.
- 在体外测试以确定蛋白质酶抑制活性 (例如,26S蛋白质酶抑制).
- 进行X射线晶体学以确定抑制剂-蛋白酶体复合体 (20S蛋白酶体) 的结构.
主要成果:
- 斯皮罗β-乳酸衍生物4显示出对26S蛋白质组的强烈抑制.
- 乳5的C-6表体表现出明显较弱的蛋白质酶抑制活性.
- 结晶学分析显示,抑制剂4和5与蛋白质酶体的催化氨酸残留物之间存在明显的相互作用.
- 乙酶复合体的水解稳定性差异被认为是强度变化的原因.
结论:
- 螺旋β-乳酸支架对开发强大的蛋白酶体抑制剂具有前景.
- 立体化学在蛋白酶体抑制的强度和机制中起着至关重要的作用.
- 来自晶体学的结构见解对于理解抑制剂-蛋白酶体相互作用和指导未来药物设计至关重要.
相关概念视频
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
Stereoisomerism of Cyclic Compounds
In this lesson, we delve into the role of ring conformation and its stability, which determines the spatial arrangement and, consequently, the molecular symmetry and stereoisomerism of cyclic compounds. 1,2-Dimethylcyclohexane is used as a case study to evaluate the possible number of stereoisomers. Here, given the multiple (n = 2) chiral centers, there are 2n = 4 possible configurations that lack a plane of symmetry, as the ring skeleton exists in a non-planar chair conformation. In addition,...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...


